Patrick Vermersch

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 327 citations · Full text

Disease Progression, Neurological Disorder, Immunology +8

Neuromyelitis optica in France

Nicolas Collongues, Romain Marignier, Hélène Zéphir et al. · Neurology · 2010 · 211 citations

Idiopathic acute transverse myelitis: Application of the recent diagnostic criteria

J. de Sèze, C. Lanctin, Irina Malikova et al. · Neurology · 2005 · 169 citations

Idiopathic Atm, Surgical Pathology, Diagnosis +7

Acute Fulminant Demyelinating Disease

J. de Sèze, Marc Debouverie, Hélène Zéphir et al. · Archives of Neurology · 2007 · 164 citations